Increased expression of ADAM33 and ADAM8 with disease progression in asthma
about
ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6Biomarkers and severe asthma: a critical appraisalRecent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinicStructure of human ADAM-8 catalytic domain complexed with batimastatADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammationThe metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthmaADAM8: a new therapeutic target for asthmaRole of ADAM and ADAMTS metalloproteinases in airway diseases.Variants of asthma and chronic obstructive pulmonary disease genes and lung function decline in aging.Association of ADAM33 gene polymorphisms with allergic asthma.Extracellular proteases as targets for drug developmentAssociation study on ADAM33 polymorphisms in mite-sensitized persistent allergic rhinitis in a Chinese populationAn ADAM33 polymorphism associates with progression of preschool wheeze into childhood asthma: a prospective case-control study with replication in a birth cohort study.Identification of ATPAF1 as a novel candidate gene for asthma in children.Soluble IgE receptors--elements of the IgE network.Current and future biomarkers in allergic asthma.An Interleukin 13 Polymorphism Is Associated with Symptom Severity in Adult Subjects with Ever Asthma.Regulation of a disintegrin and metalloprotease-33 expression by transforming growth factor-β.Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.Airway epithelial cells from asthmatic children differentially express proremodeling factorsLeukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.From bedside to bench to clinic trials: identifying new treatments for severe asthmaUnravelling the role of ADAM 33 in asthma.Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls.Immunologic and inflammatory mechanisms that drive asthma progression to remodelingFunctional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cellsA novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.Role of biomarkers in understanding and treating children with asthma: towards personalized care.Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.Asthma genetics: personalizing medicine.Advances in mechanisms of asthma, allergy, and immunology in 2008.Allergy-specific Phenome-Wide Association Study for Immunogenes in Turkish Children.An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy?Association of ADAM33 gene polymorphisms with asthma in the Uygur population of ChinaThe role of the epithelium in airway remodeling in asthma.Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast CancerIncreased Autophagy-Related 5 Gene Expression Is Associated with Collagen Expression in the Airways of Refractory Asthmatics.ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthmaThe sentinel role of the airway epithelium in asthma pathogenesis.
P2860
Q24299559-E7F4A49B-7AA3-4B25-B3DD-EDE2E0ABC251Q26782718-D8F4D4B1-BA48-42F6-8D0C-2D7E4D74A090Q27023557-822AAD3F-FBBC-4868-9144-98AE7644FA4AQ27681067-EF729718-777A-4DC0-A051-7BF64B852D5BQ28507205-B12ED5B0-43F7-4852-9188-E76CAAFAC714Q28587244-15FC2F99-CF08-4B71-B971-62FE461E53C3Q28590394-FE6A8485-4761-4156-9FA6-D3AA79F835D1Q33587176-7EE771E0-80E9-4EE1-AD2B-DA2A74E79CF7Q33952628-2EF76E18-DA7C-4ED4-AA43-8FAE1D013E98Q35065179-2658A779-FF10-4161-9287-BA974C99917AQ35116202-8F980009-B8C1-4DA0-A4D7-FBBC2B3FF6ABQ35153902-78220B7D-EC65-4381-85CE-974816DAC617Q35175137-F21BE13B-0CF1-4DD2-A688-7A799380AAA3Q35255739-9D6F3119-666D-4C6C-A6F5-DED6FFC21313Q35491143-0D1D96AE-E776-4165-BD63-1AB8C913DC7AQ35878914-AD01DC5C-6A95-4306-A674-979459EE7B8EQ35961211-D7D477D9-5B03-4EA0-BDA2-28CF4BC92E3AQ35987171-2B5E7A79-F398-450A-A908-95C5B9E19029Q36369952-A8032FC9-D032-4D21-81A3-6DAB8DDA9D41Q36549178-C6D3F894-A2CE-45C2-9E26-DF1C1B5F700EQ36706879-3C7C834D-D6E0-4B1D-85F0-4ECFB6274E6FQ36715904-3C79711B-3320-4CDA-8276-8FE5D1DF68ABQ36981794-9803D686-57F1-4E2B-A27A-C6CDD9039658Q36994921-C21B0D8D-72AF-463A-9610-13D3F8CA9E6DQ36994938-274DE63E-83BF-4653-885D-3AE688344878Q37105324-A984A7BB-1133-4ACD-901D-E74261CD18A3Q37121905-B53F914B-E8EA-4B3A-AC83-E63B0D1A7938Q37125335-377EF84D-1011-46AA-B03E-3200B264B5FAQ37140629-B7B213DD-831C-4509-829A-4198A755E47AQ37148884-CAA0AF4A-6DD9-490C-94DB-9A41F781D6F8Q37150901-94AE0419-7CA2-459F-978F-BBD5A282F8B6Q37163582-57AB411A-B321-431A-8B09-4F198888DB8BQ37254264-624CD8F5-F3F9-457C-9C5F-E5FFF0F54763Q37255325-1BE19DF6-F4BB-41E5-A881-FAA2AA7EA9BBQ37565528-DC86F32C-D1E1-4F0D-9A07-024647C8A949Q37653475-FB1A8092-2210-4055-96DE-092716B50493Q37704788-E4457898-BEB7-4E91-A0FC-EBA309B1794AQ37729501-2C14280C-9CA5-4528-B32F-14B9AFF7EB7AQ37730662-AF86CBC7-0576-4FEB-90D9-76F66E8357E7Q37891138-0C8CA186-50FA-4836-9297-7F780E753949
P2860
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@ast
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@en
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@nl
type
label
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@ast
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@en
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@nl
prefLabel
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@ast
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@en
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@nl
P2093
P3181
P1476
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
@en
P2093
Andrea K Mogas
Catherine Lemière
James G Martin
Jamila Chakir
Jean Bourbeau
Pierre Ernst
Pierre O Fiset
Ron Olivenstein
Susan C Foley
P304
P3181
P356
10.1016/J.JACI.2006.12.665
P407
P577
2007-04-01T00:00:00Z